FDA approves Welireg and Lenvima combination for advanced renal cell carcinoma. Learn about this breakthrough treatment for ...
BigHat Biosciences secures $75M Series C to advance AI-designed protein therapeutics. Total funding reaches $223M. Discover ...
Addex Therapeutics regains full global rights to GABAB PAM portfolio from Indivior. Collaboration termination follows ...
XtalPi files FDA IND application for KQTD-126, a gut-restricted pan-TRK inhibitor for chronic intestinal pain. First-in-class ...
Johnson & Johnson's Caplyta (lumateperone) shows significant efficacy in bipolar I disorder mania. Phase III trial results presented at Psych Congress 2026.
US Treasury drafts rules allowing pharmaceutical companies to license drugs from Chinese biotech firms. Learn how new regulations affect US-China ...
Celldex reports positive Phase 3 results for barzolvolimab in chronic urticaria, meeting primary endpoints. Read the ...
Viking's VK2735 sustains 97% weight loss with monthly injections. Discover how this GLP-1/GIP agonist offers flexible ...
Siemens Healthineers and Novo collaborate to expand non-invasive blood-based testing for MASLD and MASH. Learn about this healthcare partnership.
Otsuka's ulefnersen becomes first drug to meet primary endpoint in placebo-controlled FUS-ALS trial, targeting rare genetic ...
FDA Fast Track designation for QRX003, a first-in-class treatment for peeling skin syndrome. Quoin Pharmaceuticals advances ...
Earendil Labs partners with Genentech for AI-designed bispecific antibodies in oncology. $1.5B+ deal includes $55M upfront payment and milestone targets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results